The prognostic and therapeutic role of genomic subtyping by sequencing tumor or cell-free DNA in pulmonary large-cell neuroendocrine carcinoma-Reference-Cited by-同舟云学术

The prognostic and therapeutic role of genomic subtyping by sequencing tumor or cell-free DNA in pulmonary large-cell neuroendocrine carcinoma

Published:2019-11-06 Issue: Volume: Page:clincanres.0556.2019
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Zhuo Minglei^ORCID,Guan Yanfang,Yang Xue,Hong Lingzhi,Wang Yuqi,Li Zhongwu,Chen Runzhe^ORCID,Abbas Hussein,Chang Lianpeng,Gong Yuhua^ORCID,Wu Nan,Zhong Jia,Chen Wenting,Chen Hanxiao,Dong Zhi,Zhu Xiang,Li Jianjie,Wang Yuyan,An Tongtong,Wu Meina,Wang Ziping,Wang Jiayin,Roarty Emily B,Rinsurongkawong Waree,Lewis Jeff,Roth Jack A.,Swisher Stephen G.^ORCID,Lee J. Jack,Heymach John V.^ORCID,Wistuba Ignacio I.,Kalhor Neda,Yang Ling,Yi Xin,Futreal P. Andrew,Glisson Bonnie S.,Xia Xuefeng,Zhang Jianjun,Zhao Jun

Funder

National Key R&D Program of China

UT | University of Texas MD Anderson Cancer Center

Cancer Prevention and Research Institute of Texas

MD Anderson Physician Scientist Program

The Khalifa Scholar Award

The UT Lung Specialized programs of research Excellence Grant

The T.J Martell foundation

Natural Science Foundation of Beijing Municipality

Beijing Municipal Administration of Hospitals' Youth Program

The University of Texas MD Anderson Lung Moon Shot Program

Publisher